Hemoperfusion during Coronary Angioplasty: First European Experience with a New Hemoperfusion Pump

Ebo D. de Muinck*, Joan Meeder, Christel Magielse, Victor J.J. Bom, René B. van Dijk, Gijsbertus J. Verkerke, Kong I. Lie

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review


Hemolysis tests with fresh human blood were performed in vitro with a new 5 ml, piston–type hemoperfusion pump, designed to prevent myocardial ischemia during coronary angioplasty. Despite driving pressures greater than 3 atmospheres, shear stress greater than 200 Pa, turbulent pump flow, and the presence of occlusive valves, hemolysis proved to be minimal. This effect is explained by the short amount of time that blood is subjected to mechanical forces that cause hemolysis in the system and by the small volumes of blood involved. During clinical application of the system, angina pectoris, electrocardiographic changes, and systemic blood pressure were used as parameters for myocardial ischemia. There was an effective reduction of ischemia during prolonged (10 min) balloon inflation, demonstrated by the absence of angina, minimal electrocardiographic changes, and normal blood pressure. In addition, the system proved to be safe and effective during high—risk angioplasty.

Original languageEnglish
Pages (from-to)517-522
Number of pages6
JournalArtificial organs
Issue number7
Publication statusPublished - Jul 1994
Externally publishedYes


  • Active coro nary hemoperfusion
  • Coronary angioplasty


Dive into the research topics of 'Hemoperfusion during Coronary Angioplasty: First European Experience with a New Hemoperfusion Pump'. Together they form a unique fingerprint.

Cite this